-
公开(公告)号:JP5207972B2
公开(公告)日:2013-06-12
申请号:JP2008538750
申请日:2007-10-11
Applicant: 株式会社医薬分子設計研究所
IPC: C07C59/68 , A61K31/192 , A61P7/02 , C07C233/04
CPC classification number: C07C51/00 , C07C59/64 , C07C65/24 , C07C65/28 , C07C205/06 , C07C205/34 , C07C217/86 , C07C235/80 , C07C255/37
-
公开(公告)号:JP5037001B2
公开(公告)日:2012-09-26
申请号:JP2005334823
申请日:2005-11-18
Applicant: シェブロン・オロナイト・カンパニー・エルエルシー
Inventor: フランソワ・シマード , リチャード・イー・チャーペック
IPC: C07C231/02 , C07B61/00 , C07C213/06 , C07C213/10 , C07C217/50 , C07C231/24 , C07C233/04 , C08G65/26 , C08G65/46
CPC classification number: C10L1/238 , C07C231/12 , C10L1/221 , C10L1/224 , C10L10/00 , C10L10/04 , C07C233/18
-
公开(公告)号:JP2010100622A
公开(公告)日:2010-05-06
申请号:JP2009244620
申请日:2009-10-23
Inventor: STROBEL HARTMUT , WOHLFART PAULUS , SAFAROVA ALENA , WALSER ARMIN , SUZUKI TERI , DHARANIPRAGADA RAMALINGA M , SCHOENAFINGER KARL
IPC: C07C233/04 , C07C233/65 , A61K9/02 , A61K9/06 , A61K9/08 , A61K9/10 , A61K9/107 , A61K9/12 , A61K9/16 , A61K9/20 , A61K9/28 , A61K9/30 , A61K9/36 , A61K9/48 , A61K9/50 , A61K9/72 , A61K31/165 , A61K31/166 , A61K31/18 , A61K31/194 , A61K31/222 , A61K31/341 , A61K31/343 , A61K31/357 , A61K31/36 , A61K31/38 , A61K31/381 , A61K31/40 , A61K31/404 , A61K31/405 , A61K31/415 , A61K31/416 , A61K31/4172 , A61K31/4184 , A61K31/4192 , A61K31/42 , A61K31/4245 , A61K31/427 , A61K31/433 , A61K31/435 , A61K31/4365 , A61K31/437 , A61K31/44 , A61K31/4406 , A61K31/4409 , A61K31/4425 , A61K31/4439 , A61K31/455 , A61K31/47 , A61K31/473 , A61K31/4965 , A61K31/497 , A61K31/498 , A61K31/501 , A61K31/502 , A61K31/505 , A61K31/538 , A61K31/5513 , A61P1/16 , A61P3/10 , A61P7/02 , A61P9/00 , A61P9/04 , A61P9/06 , A61P9/10 , A61P9/12 , A61P11/00 , A61P11/06 , A61P13/12 , A61P15/10 , A61P19/10 , A61P25/28 , A61P43/00 , C07C233/58 , C07C233/64 , C07C233/66 , C07C233/67 , C07C233/74 , C07C233/76 , C07C235/42 , C07C235/44 , C07C235/54 , C07C235/82 , C07C235/84 , C07C237/28 , C07C237/30 , C07C237/38 , C07C237/42 , C07C237/52 , C07C255/57 , C07C255/60 , C07C309/04 , C07C309/66 , C07C309/73 , C07C311/08 , C07C311/16 , C07C311/21 , C07C311/42 , C07C317/44 , C07C323/42 , C07C323/56 , C07C323/62 , C07D207/325 , C07D207/327 , C07D207/34 , C07D209/08 , C07D209/42 , C07D213/56 , C07D213/81 , C07D213/82 , C07D215/48 , C07D215/52 , C07D219/04 , C07D231/14 , C07D231/56 , C07D233/90 , C07D235/08 , C07D237/28 , C07D239/26 , C07D239/42 , C07D241/24 , C07D241/44 , C07D243/14 , C07D249/04 , C07D249/06 , C07D249/18 , C07D261/18 , C07D265/36 , C07D271/08 , C07D277/20 , C07D277/56 , C07D285/06 , C07D295/12 , C07D295/185 , C07D307/68 , C07D307/78 , C07D307/79 , C07D307/84 , C07D307/85 , C07D317/60 , C07D317/68 , C07D319/16 , C07D319/18 , C07D333/24 , C07D333/38 , C07D333/40 , C07D333/68 , C07D333/70 , C07D401/06 , C07D403/04 , C07D405/04 , C07D471/04 , C07D495/04
CPC classification number: C07D213/81 , C07C233/58 , C07C233/65 , C07C233/66 , C07C233/74 , C07C233/76 , C07C235/42 , C07C235/54 , C07C235/84 , C07C237/38 , C07C237/42 , C07C255/57 , C07C255/60 , C07C309/66 , C07C309/73 , C07C311/08 , C07C311/16 , C07C311/21 , C07C317/44 , C07C323/62 , C07C2601/02 , C07C2601/08 , C07C2602/08 , C07D207/34 , C07D213/56 , C07D213/82 , C07D215/48 , C07D235/08 , C07D241/24 , C07D249/04 , C07D261/18 , C07D295/185 , C07D307/78 , C07D307/84 , C07D317/60 , C07D333/24 , C07D401/06
Abstract: PROBLEM TO BE SOLVED: To provide a compound that upregulates manifestation of endothelial NO-synthase. SOLUTION: There are provided acylated indanyl amines represented by general formula (I) [wherein R 1 to R 4 are each independently selected from the group consisting of H, an unsubstituted or substituted 1-16C alkyl at one or more positions and the like; A is selected from the group consisting of CH 2 , CHOH and a CH-(1-3C alkyl); B is selected from the group consisting of CH 2 and a CH-(1-3C alkyl); and R 5 indicates an aryl group or a heteroaryl group], its pharmaceutically acceptable salt and the like and a pharmaceutical preparation containing these for curing particularly cardiovascular disorder. COPYRIGHT: (C)2010,JPO&INPIT
Abstract translation: 待解决的问题:提供上调内皮NO合成酶表现的化合物。 提供由通式(I)表示的酰化茚满胺[其中R 1和R 4彼此独立地选自H, 一个或多个位置的未取代或取代的1-16C烷基等; A选自CH 2 SB,CHOH和CH-(1-3C烷基); B选自CH 2 SB 2和CH-(1-3C烷基); R< SP> 5< SP>表示芳基或杂芳基],其药学上可接受的盐等,以及含有这些用于治疗特别是心血管疾病的药物。 版权所有(C)2010,JPO&INPIT
-
公开(公告)号:JP2000095741A
公开(公告)日:2000-04-04
申请号:JP27139698
申请日:1998-09-25
Applicant: SUMITOMO CHEMICAL CO
Inventor: NOYORI RYOJI , IWAKURA KAZUNORI , ODA YOSHIAKI
IPC: B01J31/12 , C07B61/00 , C07C231/02 , C07C233/04 , C07C233/09 , C07C233/11 , C07C235/06 , C07C235/34 , C07C253/30 , C07C255/19
Abstract: PROBLEM TO BE SOLVED: To obtain an amide in a high yield by reacting esters with amines in the presence of a specific organic tin compound. SOLUTION: The objective compound of formula III is obtained by reacting (A) esters of formula I [R1-R3 are each H, a halogen, cyano or the like; R4 is a (substituted) alkyl or the like] (e.g. 2-methyl fuloropropanate acid) with (B) amines of the formula: R5-NH2 [R5 is H, a (substituted) 6-20C aryl or the like] (e.g. 1phenylethylamine) in the presence of (C) an organic tin compound of formula II (X, Y and Z are each a 1-10C alkoxyl, alkylthio, a halogen or the like; R6 is H or a 1-3C alkyl; R7 is a 2-4C alkylene chain), e.g. 3- aminopropyltin triisopropoxide, preferably at 20-200 deg.C. Preferably, the component C in an amount of 0.001-200 mol % to the component A and the component B in the amount of 1 equivalent to the component A are respectively used in the reaction.
-
公开(公告)号:JP2000034262A
公开(公告)日:2000-02-02
申请号:JP20371799
申请日:1999-07-16
Applicant: SHUDO KOICHI
Inventor: HAMADA YOSHINORI , YAMADA ISAMU , KAMINAKA MASAO , SAKATA TERUO
IPC: A61K31/00 , A61K9/127 , A61K31/165 , A61K31/196 , A61P3/00 , C07C231/12 , C07C231/14 , C07C231/24 , C07C233/04 , C07C233/07 , C07C233/11 , C07C233/65 , C07C235/84
Abstract: PROBLEM TO BE SOLVED: To obtain a novel compound which is useful for obtaining a benzoic acid derivative comprising a specific bicyclic amide compound, having retinoid activity and useful as medicines. SOLUTION: This benzoic acid derivative is a compound expressed by formula I (R1 is a lower alkyl or an aryl; R2 and R7 are each H or a lower alkyl; R3 to R6 are each a lower alkyl), e.g. 1,2,3,4-tetrahydro-1,1,4,4-tetramethyl-6- acetaminonaphthalene. The compound of formula I is obtained by carrying out the Friedel-Crafts reaction using 1 mole of an acylated aniline derivative of formula II with preferably 1.5-2 mole of 1,4-dihalobutane derivative of formula III (X is a halogen) and preferably 1.5-2 mole of a Lewis acid (e.g. AlCl3, etc.), a protonic acid (e.g. sulfuric acid, etc.), etc., as a catalyst. As a solvent, a halogenated hydrocarbon is preferably used. It is preferable to carry out the reaction at temperatures ranging from a room temperature to a cooled temperature for 0.5-20 hours.
-
公开(公告)号:JP2991059B2
公开(公告)日:1999-12-20
申请号:JP29578994
申请日:1994-11-04
Applicant: SHINETSU KAGAKU KOGYO KK
Inventor: SATO SHINICHI , KOIKE NORYUKI , MATSUDA TAKASHI
IPC: C07C233/04 , C07C235/04 , C07C235/06 , C07C235/16 , C07D295/18 , C07F7/18 , C08G69/42
-
公开(公告)号:JP2960577B2
公开(公告)日:1999-10-06
申请号:JP17792191
申请日:1991-07-18
Applicant: ビーエーエスエフ アクチェンゲゼルシャフト
Inventor: HANSU KIIFUAA , BERUNAA ROITEMAN
IPC: C07C51/50 , C07C51/48 , C07C53/02 , C07C53/08 , C07C53/122 , C07C57/07 , C07C231/02 , C07C233/04 , C07C233/05 , C07C233/06 , C07C233/07
-
公开(公告)号:JPH10511100A
公开(公告)日:1998-10-27
申请号:JP53359696
申请日:1996-06-05
IPC: B01J31/12 , C07B61/00 , C07C231/12 , C07C233/04 , C07C233/46 , C07C303/22 , C07C303/32 , C07C309/42
-
公开(公告)号:JPH10212252A
公开(公告)日:1998-08-11
申请号:JP1550197
申请日:1997-01-29
Applicant: SUMITOMO CHEMICAL CO
Inventor: MATSUMOTO MITSUHIRO , HAZAMA YASUO
IPC: C07C15/50 , C07C29/36 , C07C35/21 , C07C231/10 , C07C233/03 , C07C233/04 , C07C233/11 , C07C233/65
Abstract: PROBLEM TO BE SOLVED: To obtain the subject compound which is useful as a drug intermediate by allowing a benzenediazonium salt to react with α-methylstyrene in the presence of a copper catalyst under specified acidic conditions. SOLUTION: A benzenediazonium salt represented by formula I (X is a halogen) is allowed to react with an α-methylstyrene in an amount of 0.8-10 moles in the presence of a copper catalyst such as metallic copper in an acidic aqueous solution, for example, hydrogen chloride at a pH of
-
公开(公告)号:JPH10204046A
公开(公告)日:1998-08-04
申请号:JP1081897
申请日:1997-01-24
Applicant: SAGAMI CHEM RES
Inventor: KAMIMURA DAISUKE , YAMADA AKIHIRO , YAZAWA KAZUYOSHI
IPC: C07C233/04 , A01N37/18 , C07C233/05 , C07C233/06 , C07C233/07 , C07C233/13
Abstract: PROBLEM TO BE SOLVED: To obtain a new compound, having in vitro growth inhibiting activities against bacteria, capable of manifesting antifouling activities in the field, having especially high antimicrobial activities against marine attached bacteria and useful as an antimicrobial and antifouling agent. SOLUTION: This new compound is represented by the formula (R and R are each H, an aralkyl, etc.; X is Br or H), e.g. N-2-[(4-nitrophenyl) ethyl]tribromoacetamide. In the case of the N-2-[(4-nitrophenyl) ethyl]tribromoacetamide as an example, the compound represented by the formula is synthesized by adding thionyl chloride and N,N-dimethylformamide to tribromoacetic acid, carrying out the refluxing for 5hr, concentrating the reactional mixture, adding a mixture solution prepared by adding triethylamine to a solution of a 2-(4-nitrophenyl)ethylamine hydrochloride converted into a free amine in dichloromethane thereto under cooling with ice, conducting reaction at ambient temperature for 17hr, then adding a 20% aqueous solution of Na2 CO3 thereto, stirring the mixture, subsequently extracting the mixture with ethyl acetate, concentrating and purifying the resultant extract.
-
-
-
-
-
-
-
-
-